APOE epsilon 4 is associated with younger age at ischemic stroke onset but not with stroke outcome
Cecilia Lagging, Erik Lorentzen, Tara M Stanne, Annie Pedersen, Martin Soderholm, John W Cole, Katarina Jood, Robin Lemmens, Chia-Ling Phuah, Natalia S Rost, Vincent Thijs, Daniel Woo, Jane M Maguire, Arne Lindgren, Christina Jern
Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2019
This study was funded by the Swedish Heart and Lung Foundation (C. Jern and A. Lindgren); the Swedish Research Council (C. Jern); the Swedish Stroke Association (C. Jern and A. Lindgren); the Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement (C. Jern and A. Lindgren); the Gothenburg Foundation for Neurological Research (C. Lagging); the Freemasons Lodge of Instruction EOS in Lund (A. Lindgren); the Foundation of Fars & Frosta-one of Sparbanken Skane's ownership foundations (A. Lindgren); Lund University (A. Lindgren); Region Skane, Skane University Hospital (A. Lindgren); the National Health and Medical Research Council, Australia (J.M. Maguire); the National Institutes of Health (J. Cole); the US Department of Veterans Affairs (J. Cole); the American Heart Association (AHA) Cardiovascular Genome-Phenome Study (J. Cole); and the NIH-NINDS (N.S. Rost). Funding for the entire GISCOME study is listed in Soderholm et al. Genome-wide association meta-analysis of functional outcome after ischemic stroke.